FDA Inspection 1305568 — Neilmed Pharmaceuticals Inc

Neilmed Pharmaceuticals Inc — FEI 3002998723

The FDA completed an inspection of Neilmed Pharmaceuticals Inc on Jul 22, 2026 in Santa Rosa, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 22, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Santa Rosa, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111121 CFR 211.25(a)Training , Education , Experience overall
121521 CFR 211.67(b)Written procedures not established/followed
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
184421 CFR 211.84(d)(2)Establish reliability of supplier's C of A
434021 CFR 211.142Written warehousing procedures established/followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.